Chongqing Porton Pharmaceutical Technology Overview
- Year Founded
-
2005
- Status
-
Public
- Employees
-
5,332
- Stock Symbol
-
300363
- Investments
-
4
- Share Price
-
$4.07
- (As of Friday Closing)
Chongqing Porton Pharmaceutical Technology General Information
Description
Porton Pharma Solutions Ltd is a China-based external manufacturing supplier of custom drug intermediates and Active Pharmaceutical Ingredients (APIs) to pharmaceutical companies. It is engaged in the process development activities and pilot-scale and commercial-scale manufacturing activities.
Contact Information
Website
www.porton.cn
Formerly Known As
Porton Fine Chemicals
Ownership Status
Publicly Held
Financing Status
Formerly PE-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
BPO/Outsource Services
Stock Exchange
SHE
Primary Office
- Number 7, Yuntu Road, Beibei District
- Shuitu
- Chongqing, 401121
- China
+86 023 0000 0000
Chongqing Porton Pharmaceutical Technology Stock Performance
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $4.07 | $4.07 | $3.20 - $7.69 | $2.22B | 546M | 12.6M | $0.23 |
Chongqing Porton Pharmaceutical Technology Financials Summary
|
In Thousands, USD |
TTM 30-Sep-2023 | FY 2022 31-Dec-2022 | FY 2021 31-Dec-2021 | FY 2020 31-Dec-2020 |
|---|---|---|---|---|
| EV | 2,014,245 | 2,962,916 | 7,558,150 | 2,905,437 |
| Revenue | 688,188 | 1,044,585 | 480,891 | 299,898 |
| EBITDA | 140,567 | 372,764 | 115,909 | 71,919 |
| Net Income | 124,690 | 297,785 | 81,138 | 46,958 |
| Total Assets | 1,245,798 | 1,470,337 | 1,029,484 | 704,248 |
| Total Debt | 183,012 | 133,893 | 116,216 | 79,098 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Chongqing Porton Pharmaceutical Technology Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Chongqing Porton Pharmaceutical Technology Patents
Chongqing Porton Pharmaceutical Technology Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4119671-A1 | Method for synthesizing (s)-nicotine | Pending | 10-Mar-2020 | 0000000000 | |
| CA-3108358-A1 | Preparation method for (1r,3s)-3-amino-1-cyclopentanol and salts thereof | Active | 28-Aug-2018 | 0000000000 | |
| CA-3108358-C | Preparation method for (1r,3s)-3-amino-1-cyclopentanol and salts thereof | Active | 28-Aug-2018 | 0000000000 | |
| EP-3845518-A1 | Preparation method for (1r,3s)-3-amino-1-cyclopentanol and salts thereof | Pending | 28-Aug-2018 | 0000000000 | |
| EP-3845518-A4 | Preparation method for (1r,3s)-3-amino-1-cyclopentanol and salts thereof | Pending | 28-Aug-2018 | C07C213/00 | 0 |
Chongqing Porton Pharmaceutical Technology Executive Team (5)
Chongqing Porton Pharmaceutical Technology Board Members (2)
| Name | Representing | Role | Since |
|---|---|---|---|
| 00000000 00 | Chongqing Porton Pharmaceutical Technology | Chief Executive Officer & Chairman | 000 0000 |
| 0000 000 | Chongqing Porton Pharmaceutical Technology | Co-Founder, Vice Chairman, Secretary & Deputy General Manager | 000 0000 |
Chongqing Porton Pharmaceutical Technology Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Chongqing Porton Pharmaceutical Technology Investments & Acquisitions (4)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Porton Advanced Solutions | 19-Aug-2022 | 00000 0000 | 000.00 | Drug Discovery | |
| HSOhealth | 01-Sep-2017 | 00000 0000 | Insurance Brokers | ||
| J-Star Research | 01-May-2017 | 0000000000 | 0000 | BPO/Outsource Services | 00000000 |
| Jiangxi Dongbang Pharmaceutical | 01-Jul-2015 | Merger/Acquisition | 000.00 | Pharmaceuticals |
Chongqing Porton Pharmaceutical Technology Subsidiaries (2)
| Company Name | Industry | Location | Founded |
|---|---|---|---|
| Jiangxi Dongbang Pharmaceutical | Pharmaceuticals | Fengxin County, China | 2007 |
| J-Star Research | BPO/Outsource Services | South Plainfield, NJ | 0000 |
Chongqing Porton Pharmaceutical Technology ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Pharmaceuticals
Subindustry
Rank
Percentile
